| MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases TPN Nguyen, M Kumar, E Fedele, G Bonanno, T Bonifacino International Journal of Molecular Sciences 23 (9), 4718, 2022 | 58 | 2022 |
| Opportunities and challenges in application of artificial intelligence in pharmacology M Kumar, TP Nguyen, J Kaur, TG Singh, D Soni, R Singh, P Kumar Pharmacological Reports, 1-16, 2023 | 54 | 2023 |
| Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral … M Milanese, T Bonifacino, C Torazza, F Provenzano, M Kumar, S Ravera, ... British journal of pharmacology 178 (18), 3747-3764, 2021 | 22 | 2021 |
| Insights into Human-Induced Pluripotent Stem Cell-Derived Astrocytes in Neurodegenerative Disorders M Kumar, NTP Nguyen, M Milanese, G Bonanno Biomolecules 12 (3), 344, 2022 | 17 | 2022 |
| Montelukast improves disease outcome in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity S Raffaele, N Nguyen, M Milanese, FC Mannella, M Boccazzi, ... British Journal of Pharmacology, 2024 | 3 | 2024 |
| A repurposing approach to delay disease progression in SOD1G93A mice by counteracting oligodendrocyte dysfunction S Raffaele, T Bonifacino, N Nguyen, M Boccazzi, G Frumento, M Milanese, ... GLIA 71, E316-E317, 2023 | | 2023 |
| Effects of the GPR17 antagonist montelukast on oligodendrocyte dysfunction and disease outcome in the SOD1G93A mouse model of ALS T Bonifacino, S Raffaele, N Nguyen, M Milanese, G Bonanno, ... GLIA 69, E202-E202, 2021 | | 2021 |
Giambattista BonannoFull Professor of Pharmacology - University of Genoa (Italy)Verifisert e-postadresse på difar.unige.it